Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index

被引:35
|
作者
Cohen, Ricardo [1 ]
Caravatto, Pedro Paulo
Correa, Jose Luis
Noujaim, Patricia
Petry, Tarissa Zanata
Salles, Joao Eduardo
Schiavon, Carlos Aurelio
机构
[1] Hosp Alemao Oswaldo Cruz, Ctr Surg Treatment Morbid & Metab Disorders, Dept Surg, BR-01411000 Sao Paulo, Brazil
关键词
Bariatric surgery; Glucose metabolism; Insulin sensitivity; GASTRIC BYPASS; WEIGHT-LOSS; INSULIN-RESISTANCE; TYPE-2; OBESITY; GLUCOSE; DIET;
D O I
10.1016/j.soard.2012.01.017
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bariatric surgery frequently results in the resolution of type 2 diabetes mellitus (T2DM). One of the many factors that could explain such findings is the duodenal exclusion of the alimentary tract. To test this hypothesis, a surgical model that induces glycemic control without significant weight loss would be ideal. In the present study, we evaluated the early metabolic changes that occur in overweight diabetic patients after laparoscopic duodenal-jejunal bypass (DJB) and determined the factors associated with success in T2DM resolution. The setting was a private practice. Methods: A total of 35 patients (20 men and 15 women) were included in the present study. The mean preoperative body mass index was 28.4 +/- 2.9 kg/m(2). DJB was performed in all patients, and the anthropometric data and blood samples were collected at baseline (preoperatively) and 3, 6, 9, and 12 months after surgery. Success was defined when patients reached a glycated hemoglobin level of <7% without diabetic medication. Results: T2DM remission was observed in 14 (40%) of 35 patients. No differences in the homeostasis model assessment insulin resistance index levels and patient weight were observed before and 12 months after DJB surgery. Gender, duration of T2DM, previous use of insulin, preoperative homeostasis model assessment insulin resistance index, and C-peptide levels were not significant predictive factors of success or nonsuccess. The only factor that significantly predicted postoperative positive outcomes was a waist circumference reduction of >= 7% compared with baseline within the first 6 months after surgery. Conclusion: DJB improves glycemic control; however, it does not increase insulin sensitivity in overweight diabetic patients. These changes were observed without significant weight loss. (Surg Obes Relat Dis 2012;8:375-380.) (c) 2012 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [21] The effect of serum activated ghrelin hormone on glycemic control in the diabetic patients with excessive body mass index
    Faki, Yilmaz
    Kalyon, Semih
    MARMARA MEDICAL JOURNAL, 2023, 36 (02): : 171 - 174
  • [22] Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study
    Laubner, Katharina
    Riedel, Nina
    Fink, Katharina
    Holl, Reinhard W.
    Welp, Reinhard
    Kempe, Hans-Peter
    Lautenbach, Anne
    Schlensak, Matthias
    Stengel, Rainer
    Eberl, Thomas
    Dederichs, Frank
    Schwacha, Henning
    Seufert, Jochen
    Aberle, Jens
    DIABETES OBESITY & METABOLISM, 2018, 20 (08) : 1868 - 1877
  • [23] Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
    Betzel, B.
    Cooiman, M. I.
    Aarts, E. O.
    Janssen, I. M. C.
    Wahab, P. J.
    Groenen, M. J. M.
    Drenth, J. P. H.
    Berends, F. J.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2020, 34 (01): : 209 - 215
  • [24] Duodenal-jejunal bypass surgery on type 2 diabetic rats reduces the expression of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the thoracic aorta
    Maimaitiyusufu, Wubulikasimu
    Han Haifeng
    Yan Zhibo
    Zhang Xiang
    Liu Shaozhuang
    Zhang Guangyong
    Kasimu, Aimaiti
    Hu Sanyuan
    CHINESE MEDICAL JOURNAL, 2014, 127 (13) : 2423 - 2428
  • [25] Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model
    Wu, Dong
    Cheng, Yu-gang
    Huang, Xin
    Zhong, Ming-wei
    Liu, Shao-zhuang
    Hu, San-yuan
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2018, 74 (03) : 431 - 439
  • [26] Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years
    Sepulveda, Matias
    Alamo, Munir
    Preiss, Yudith
    Valderas, Juan P.
    OBESITY SURGERY, 2018, 28 (11) : 3466 - 3473
  • [27] Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal-jejunal bypass
    Huang, Xin
    Wu, Dong
    Cheng, Yugang
    Zhang, Xiang
    Liu, Teng
    Liu, Qiaoran
    Xia, Pingtian
    Zhang, Guangyong
    Hu, Sanyuan
    Liu, Shaozhuang
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 626 - 638
  • [28] Trends in BMI, Glycaemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL)
    Kassir, Radwan
    Gugenheim, Jean
    Ben Amor, Imed
    Kassir, Rani
    Sauvat, Frederique
    OBESITY SURGERY, 2018, 28 (11) : 3629 - 3630
  • [29] Intestinal rearrangement of biliopancreatic limbs, alimentary limbs, and common limbs in obese type 2 diabetic mice after duodenal jejunal bypass surgery
    Li, Heng
    He, Jipei
    Hou, Jie
    He, Chengjun
    Dai, Xiaojiang
    Song, Zhigao
    Liu, Qing
    Wang, Zixin
    Huang, Hongyan
    Ding, Yunfa
    Qi, Tengfei
    Zhang, Hongbin
    Wu, Liangping
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [30] Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons
    Shahmiri, Shahab Shahabi
    Parmar, Chetan
    Yang, Wah
    Lainas, Panagiotis
    Pouwels, Sjaak
    Davarpanahjazi, Amir Hossein
    Chiappetta, Sonja
    Seki, Yosuke
    Omar, Islam
    Vilallonga, Ramon
    Kassir, Radwan
    Abbas, Syed Imran
    Bashir, Ahmad
    Singhal, Rishi
    Kow, Lilian
    Kermansaravi, Mohammad
    BMC SURGERY, 2023, 23 (01)